ACCESS Newswire Inc. ACCS
DESCRIPTION OF BUSINESS.
its subsidiaries are hereinafter collectively referred to as "ACCESS", "ACCESS Newswire", the "Company",
"We" or "Our" unless otherwise noted.
formed in October 1988 under the name Docucon Incorporated. In December 2007, we changed our name to Issuer Direct Corporation,
Last close
5.33
2026-09-04
Market cap
$20.4M
2026-06-30 share count
52-week range
4.74 - 11.35
Valuation FY2025 figures against the last close
P/S0.9x
P/E4.8x
P/FCF37.9x
EV/EBITDA17.8x
Dividend yield—
Diluted EPS1.11
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.6M | $23.1M | $24.5M | $23.5M | $21.9M | $18.5M | $16.3M | $14.2M | $12.6M | $12.1M |
| Cost of revenue | $5.3M | $5.6M | $5.6M | $5.7M | $5.7M | $5.4M | $5.1M | $4.1M | $3.4M | $3.0M |
| Gross profit | $17.3M | $17.4M | $18.9M | $17.8M | $16.1M | $13.1M | $11.2M | $10.1M | $9.2M | $9.0M |
| R&D | $2.7M | $2.8M | $2.5M | $1.3M | $1.1M | $825.0K | $1.2M | $1.3M | $763.0K | $404.0K |
| SG&A | $7.2M | $7.0M | $8.4M | $7.0M | $5.8M | $5.0M | $5.1M | $4.1M | $3.4M | $3.2M |
| Total operating expenses | $19.2M | $33.8M | — | $15.2M | $12.4M | $10.4M | $10.7M | $9.0M | $7.2M | $7.1M |
| Operating income | -$1.9M | -$16.3M | -$2.7M | $2.7M | $3.7M | $2.7M | $474.0K | $1.2M | $2.0M | $1.9M |
| Interest expense | $2.0K | $1.1M | $1.2M | $11.0K | $3.0K | $56.0K | $321.0K | $47.0K | $2.0K | $4.0K |
| Pre-tax income | -$2.0M | -$17.3M | -$4.4M | $2.7M | $4.1M | $451.0K | $795.0K | $1.2M | $2.0M | $2.0M |
| Income tax | $395.0K | $4.1M | $938.0K | $724.0K | $821.0K | $724.0K | $109.0K | $373.0K | $131.0K | $464.0K |
| Net income | $4.3M | -$10.8M | $766.0K | $1.9M | $3.3M | $2.1M | $686.0K | $837.0K | $1.9M | $1.6M |
| EPS, basic | 1.11 | -2.82 | 0.20 | 0.52 | 0.87 | 0.56 | 0.18 | 0.25 | 0.63 | 0.55 |
| EPS, diluted | 1.11 | -2.82 | 0.20 | 0.52 | 0.86 | 0.56 | 0.18 | 0.24 | 0.62 | 0.54 |
| Shares, diluted (wtd. avg.) | $3.9M | $3.8M | $3.8K | $3.7M | $3.8M | $3.8M | $3.9K | $3.5M | $3.0M | $2.9M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $3.0M | $4.1M | $5.7M | $4.8M | $23.9M | $19.6M | $15.8M | $17.2M | $4.9M | $5.3M |
| Receivables | $3.9M | $3.4M | $3.0M | $3.0M | — | — | — | — | — | — |
| Total current assets | $8.4M | $10.0M | $11.5M | $9.4M | $27.9M | $22.4M | $18.0M | $19.0M | $7.1M | $6.8M |
| Property, plant and equipment | $136.0K | $365.0K | $495.0K | $625.0K | $713.0K | $795.0K | $899.0K | $132.0K | $145.0K | $204.0K |
| Goodwill | $19.0M | $19.0M | $19.0M | $22.5M | $6.4M | $6.4M | $6.4M | $5.0M | $4.1M | $2.2M |
| Other intangibles | $9.5M | $12.0M | $28.7M | $32.2M | $2.4M | $2.9M | $3.5M | $2.8M | $2.9M | $1.4M |
| Total assets | $42.0M | $50.6M | $65.2M | $66.3M | $39.3M | $34.9M | $32.4M | $29.0M | $16.9M | $12.9M |
| Accounts payable | $1.5M | $1.4M | $1.2M | $1.4M | $695.0K | $304.0K | $266.0K | $371.0K | $666.0K | $343.0K |
| Short-term debt | $870.0K | $4.0M | $4.0M | $22.0M | — | — | — | — | — | — |
| Total current liabilities | $9.5M | $12.8M | $12.7M | $31.2M | $5.8M | $4.6M | $3.8M | $2.6M | $2.5M | $2.1M |
| Long-term debt | $1.7M | $11.9M | $15.9M | $0 | — | — | — | — | — | — |
| Total liabilities | $11.6M | $25.4M | $29.7M | $33.1M | $7.6M | $6.7M | $6.3M | $3.3M | $3.7M | $2.3M |
| Retained earnings | $5.4M | $1.1M | $11.9M | $11.2M | $9.2M | $5.9M | $3.8M | $3.2M | $2.8M | $1.5M |
| Total equity | $30.3M | $25.2M | $35.4M | $33.2M | $31.6M | $28.1M | $26.1M | $25.7M | $13.2M | $10.6M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $558.0K | $3.2M | $3.1M | $4.0M | $4.7M | $4.4M | $2.9M | $2.9M | $2.5M | $2.8M |
| Depreciation and amortisation | $3.0M | $3.1M | $2.8M | $1.0M | $1.1M | $1.3M | $1.7M | $1.4M | $735.0K | $1.1M |
| Stock-based compensation | $884.0K | $684.0K | $1.4M | $763.0K | $333.0K | $273.0K | $523.0K | $629.0K | $516.0K | $592.0K |
| Capital expenditure | $20.0K | $19.0K | $25.0K | $66.0K | $62.0K | $27.0K | $420.0K | $51.0K | $11.0K | $112.0K |
| Investing cash flow | $11.8M | -$616.0K | -$153.0K | -$18.0M | -$277.0K | -$27.0K | -$3.2M | -$1.2M | -$2.8M | -$1.2M |
| Financing cash flow | -$13.6M | -$4.0M | -$2.1M | -$4.9M | -$146.0K | -$574.0K | -$1.1M | $10.7M | -$199.0K | -$418.0K |
| Dividends paid | — | — | — | $0 | $0 | $0 | $0 | $460.0K | $588.0K | $453.0K |
| Buybacks | — | — | $0 | $5.0M | $453.0K | $785.0K | $773.0K | $2.6M | $0 | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001683168-26-003382.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $8.76B | 10.6x | -6.4% |
| G | Genpact LTD | $6.27B | 11.9x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.19B | 18.4x | 2.4% |
| EXPO | EXPONENT INC | $3.25B | 33.0x | 4.2% |
| HURN | Huron Consulting Group Inc. | $2.52B | 26.6x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.14B | 83.6x | 56.4% |
| ICFI | ICF International, Inc. | $1.58B | 17.8x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $735.5M | 58.1x | 14.9% |